Beta The Briev beta is out. Free on iPhone via TestFlight — install it in under a minute.

Join the beta ↗
Briev
Live
Health

Comedian probes why men stay silent about prescription weight-loss injections

A 53-year-old comedian shares his own experience losing weight with drugs like Wegovy and questions why men rarely discuss using such treatments.

At 53 and previously tipping the scales at more than 35 stone, the comedian turned to a prescription weight-loss injection, shedding over 8 stone after an initial diet phase. He found that, despite growing private use of drugs such as Wegovy and Mounjaro across England, Wales and Scotland, men tend to keep their usage private, unlike women who discuss weight loss openly. Interviews with men like Barry from Chester-le-Street, who dropped from 25 stone to 19 stone 5 lb, illustrate both the dramatic results and the reluctance to talk about the treatment due to fear of judgment or side-effects.

Public health researcher Jack Birch notes that men often need a strong scare to consider the drugs and that secrecy may impede medical oversight. GP Paul Evans in Gateshead observes a rising but concealed male patient base, stressing the need to remove shame around pharmaceutical assistance. The comedian concludes that broader openness and lifestyle changes are essential for lasting health improvements.

Why it matters

Understanding men's silence on weight-loss drugs helps address hidden health risks and improve medical support.

In this story

weight-loss drugsmen's healthobesityWegovyMounjarostigmaprivate pharmacyNorth Eastpublic health
Get the beta ↗